Evidence map›Paper›PMID 42133484›Full record

ArticleJournal of the American Chemical Society2026

Enantioconvergent Chan-Evans-Lam C(sp

Tanner J Schubert, Ambre Carpentier, Yongxian Li, Kolter C Hubbell, Jeewhan Oh, Shao-Liang Zheng, Robert S Paton, Yuyang Dong

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tanner J SchubertDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States.
Ambre CarpentierDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States.
Yongxian LiDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States.
Kolter C HubbellDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States.
Jeewhan OhDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.ORCID 0009-0003-1442-5704
Shao-Liang ZhengDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.ORCID 0000-0002-6432-9943
Robert S PatonDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States.ORCID 0000-0002-0104-4166
Yuyang DongDepartment of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States.ORCID 0000-0002-4533-4798

Funding

Computational Models for New Developments in Radical ChemistryR01GM151533 · NIGMS · COLORADO STATE UNIVERSITY · PI Robert Scott Paton · 2023 to 2026
$1.2M
NIGMS NIH HHS R01 GM151533
6 · The paper itself

Abstract

While alkylborane oxidation constitutes one of the most widely utilized strategies to construct C-O bonds, asymmetric versions of this transformation remain elusive. Establishing such an asymmetric approach would unlock a strategically distinct disconnection to oxygen-bearing stereogenic centers, which are ubiquitous across biologically active scaffolds. Herein, we employ a Cu-catalyzed single-electron mechanism to achieve enantioconvergent alkylborane oxidation for the first time. The central challenge─suppressing the unselective carbocation pathway from alkyl radical oxidation by the Cu(II)-carboxylate─is addressed by (1) lowering the reaction temperature to attenuate the undesired radical-polar crossover while (2) leveraging photochemical activation to preserve the single-electron radical functionalization manifold. The reaction exhibits broad functional-group compatibility, engaging benzyl- and allylboronic esters; diverse carboxylic acids, including complex pharmaceutical substructures and heterocycle-containing substrates, are also well tolerated. The reported protocol is scalable to gram quantities and was utilized for the asymmetric synthesis of an immunosuppressant drug candidate. Mechanistic studies, including stoichiometric interrogation of elementary steps, rate law determination, radical trapping experiments, and density functional theory (DFT) computations, indicate that the reaction operates by balancing two light-driven processes: (1) rate-determining N-H bond homolysis followed by N-radical-mediated C-B bond activation and (2) enantioselective Cu-mediated radical functionalization via an inner-sphere pathway. The reactive Cu(II)-carboxylate intermediate was isolated and structurally characterized, permitting direct examination of its spectroscopic features and radical-trapping reactivity. Electron paramagnetic resonance (EPR) studies identified the Cu(II)-carboxylate species as the catalyst resting state, and stoichiometric reaction of the Cu(II)-carboxylate with a persistent trityl radical demonstrated its competency for C-O bond formation. Hammett analysis further revealed that the efficiency of C-O bond formation is governed by the electrophilicity of the Cu(II)-carboxylate intermediate.

Identifiers

PMID42133484
PMCPMC13198982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.